sglt2 with glp 1 Diabetic Agents, From Metformin to Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar Recommendations for SGLT2i versus GLP-1

The biological basis for this lies in neuroinflammation, driven by the unique anatomical pathway between the sinuses and the brain

Many individuals begin noticing looser-fitting clothing around the waist within the first few months of starting therapy, though significant visible reduction typically requires several months of consistent treatment

GLP-1 medication: BMI 30+ or BMI 27+ with weight-related condition

The two medications have some key differences

Direct support for diabetes, obesity, and next-gen GLP-1 treatments

Returning to the definition of half-life as the time required for the blood level to drop by half, if the steady state blood level of a drug with linear pharmacokinetics is considered to be 100%, then, if the drug is suddenly withdrawn, its level will drop to 50% after the first half-life, to 25% after the second half-life, to 12.5% after the third half-life, to 6.25% after the fourth half-life, and to 3.125% after the fifth half-life (Figure 1)